Emerging opportunities in East Asia

Forecast by information solutions provider IMS Health to be the second, third, and 14th biggest spenders, respectively, in medicine by 2017, and with a combined population of more than 1.5 billion people, China, Japan and South Korea are becoming key markets for the big pharma and biotech companies.